Physician profile
Mark C Nation
NPI 1093808735
$179,631.94
in general payments reported to CMS, 2019-2025
12 companies · $26K in 2025
The $26K reported for 2025 was more than what 97% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52K · 2020: $8,294 · 2021: $12K · 2022: $12K · 2023: $31K · 2024: $38K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $54K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Travel and Lodging: $10K · Food and Beverage: $1,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $54,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29,558.00 |
| Travel and Lodging | $10,228.13 |
| Food and Beverage | $1,522.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $76,145.29 | 2019-2025 | Astra Tech Implant System, Implant Dentistry, Atlantis |
| Straumann USA LLC | $67,081.63 | 2019-2025 | |
| Dentsply Ih INC. | $35,027.85 | 2019-2021 | |
| Nobel Biocare USA | $562.76 | 2019-2021 | |
| Salvin Dental Specialties, INC. | $413.37 | 2021 | |
| Geistlich Pharma, North America, INC. | $180.27 | 2019-2025 | Biomaterials |
| Peter Brasseler Holdings, LLC | $69.99 | 2019-2024 | |
| Biohorizons Implant Systems INC. | $50.74 | 2024 | Biohorizons |
| Align Technology, INC. | $31.28 | 2024 | Invisalign |
| Voco America INC. | $29.94 | 2019-2025 | Bifix Qm, Grandio So, Clip |
| Gc America INC. | $20.34 | 2023 | Cytrans |
| Pacira Pharmaceuticals Incorporated | $18.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Nation listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.